H. Pylori

>

Latest News

FDA Approves RHB-105 to Treat H Pylori
FDA Approves RHB-105 to Treat H Pylori

November 4th 2019

RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies.

Antibiotic-Resistant H Pylori is on the Rise in Europe
Antibiotic-Resistant H Pylori is on the Rise in Europe

October 23rd 2019

Gut Bacteria "Mismatch" Could Increase Gastric Cancer Risk
Gut Bacteria "Mismatch" Could Increase Gastric Cancer Risk

April 11th 2017

Top 5 Contagion® News Articles for the Month of March 2017
Top 5 Contagion® News Articles for the Month of March 2017

April 5th 2017

Risk Marker for Stomach Cancer Uses Acid Sensors to Control Colonization
Risk Marker for Stomach Cancer Uses Acid Sensors to Control Colonization

March 1st 2017

© 2024 MJH Life Sciences

All rights reserved.